Synthetic biology firm Amyris announced that it has delivered its first shipment of fermentation-made cannabinoid molecules to LAVVAN that will be utilized in industries that manufacture personal care and beauty products. LAVVAN's clients include companies in the food, beverage and pharmaceutical industries, and their strategic partnership with Amyris is expected to build the latter's position as a leading synthetic biology company.
Amyris aims to become leading synthetic biology firm
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.